These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

839 related items for PubMed ID: 17088110

  • 1. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications.
    Goldstein JL, Howard KB, Walton SM, McLaughlin TP, Kruzikas DT.
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1337-45. PubMed ID: 17088110
    [Abstract] [Full Text] [Related]

  • 2. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
    Wolfe F, Anderson J, Burke TA, Arguelles LM, Pettitt D.
    J Rheumatol; 2002 Mar; 29(3):467-73. PubMed ID: 11908558
    [Abstract] [Full Text] [Related]

  • 3. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
    Ray WA, Chung CP, Stein CM, Smalley WE, Hall K, Arbogast PG, Griffin MR.
    Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591
    [Abstract] [Full Text] [Related]

  • 4. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [Abstract] [Full Text] [Related]

  • 5. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL.
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [Abstract] [Full Text] [Related]

  • 6. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A, Franceschi M, Leandro G, Paris F, Cascavilla L, Longo MG, Niro V, Andriulli A, Scarcelli C, Di Mario F.
    Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1091-7. PubMed ID: 15569111
    [Abstract] [Full Text] [Related]

  • 7. Adherence to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and haemorrhage.
    van Soest EM, Sturkenboom MC, Dieleman JP, Verhamme KM, Siersema PD, Kuipers EJ.
    Aliment Pharmacol Ther; 2007 Jul 15; 26(2):265-75. PubMed ID: 17593072
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the effects of diclofenac or other non-steroidal anti-inflammatory drugs (NSAIDs) and diclofenac or other NSAIDs in combination with proton pump inhibitors (PPI) on hospitalisation due to peptic ulcer disease.
    Höer A, Gothe H, Schiffhorst G, Sterzel A, Grass U, Häussler B.
    Pharmacoepidemiol Drug Saf; 2007 Aug 15; 16(8):854-8. PubMed ID: 17323403
    [Abstract] [Full Text] [Related]

  • 9. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
    Turajane T, Wongbunnak R, Patcharatrakul T, Ratansumawong K, Poigampetch Y, Songpatanasilp T.
    J Med Assoc Thai; 2009 Dec 15; 92 Suppl 6():S19-26. PubMed ID: 20128070
    [Abstract] [Full Text] [Related]

  • 10. Proton pump inhibitor co-therapy with nonsteroidal anti-inflammatory drugs--nice or necessary?
    Laine L.
    Rev Gastroenterol Disord; 2004 Dec 15; 4 Suppl 4():S33-41. PubMed ID: 15580145
    [Abstract] [Full Text] [Related]

  • 11. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice.
    Moore RA, Derry S, Phillips CJ, McQuay HJ.
    BMC Musculoskelet Disord; 2006 Oct 20; 7():79. PubMed ID: 17054784
    [Abstract] [Full Text] [Related]

  • 12. [Prevention and treatment of non-steroidal anti-inflammatory drug gastroenteropathy].
    Lanas A.
    Rev Gastroenterol Mex; 2004 Oct 20; 69(4):251-60. PubMed ID: 15765979
    [Abstract] [Full Text] [Related]

  • 13. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants.
    Lanas A, García-Rodríguez LA, Arroyo MT, Bujanda L, Gomollón F, Forné M, Aleman S, Nicolas D, Feu F, González-Pérez A, Borda A, Castro M, Poveda MJ, Arenas J, Investigators of the Asociación Española de Gastroenterología (AEG).
    Am J Gastroenterol; 2007 Mar 20; 102(3):507-15. PubMed ID: 17338735
    [Abstract] [Full Text] [Related]

  • 14. COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors.
    van der Linden MW, Gaugris S, Kuipers EJ, van Herk-Sukel MP, van den Bemt BJ, Sen SS, Herings RM.
    Pharmacoepidemiol Drug Saf; 2009 Oct 20; 18(10):880-90. PubMed ID: 19593747
    [Abstract] [Full Text] [Related]

  • 15. Inadequate prevention of NSAID-induced gastrointestinal events.
    Herings RM, Goettsch WG.
    Ann Pharmacother; 2004 May 20; 38(5):760-3. PubMed ID: 15031416
    [Abstract] [Full Text] [Related]

  • 16. GI risk factors and use of GI protective agents among patients receiving nonsteroidal antiinflammatory drugs.
    Harris CL, Raisch DW, Abhyankar U, Marfatia S, Campbell HM, Sather MR.
    Ann Pharmacother; 2006 Nov 20; 40(11):1924-31. PubMed ID: 17047140
    [Abstract] [Full Text] [Related]

  • 17. Impact of compliance with proton pump inhibitors on NSAID treatment.
    Duh MS, Gosselin A, Luo R, Lohoues H, Lewis BE, Crawley JA.
    Am J Manag Care; 2009 Oct 20; 15(10):681-8. PubMed ID: 19845420
    [Abstract] [Full Text] [Related]

  • 18. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs.
    Targownik LE, Metge CJ, Leung S, Chateau DG.
    Gastroenterology; 2008 Apr 20; 134(4):937-44. PubMed ID: 18294634
    [Abstract] [Full Text] [Related]

  • 19. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S, Ittel TH, Wietholtz H.
    Z Gastroenterol; 2003 Aug 20; 41(8):719-28. PubMed ID: 12910426
    [Abstract] [Full Text] [Related]

  • 20. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL, Huang B, Amer F, Christopoulos NG.
    Clin Ther; 2004 Oct 20; 26(10):1637-43. PubMed ID: 15598480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.